Santé Canada
Symbole du gouvernement du Canada

Liens de la barre de menu commune

Sécurité des produits de consommation

Déclaration d'incident

Sous-formulaire I: Renseignements généraux

1.Type de rapport.

Nouvelle déclaration d'incident

No de la demande: 2015-0749

2. Renseignements concernant le titulaire.

Numéro de référence du titulaire d'homologation: 1487527

Nom du titulaire (nom légal complet, aucune abbréviation): McLaughlin Gormley King Company

Adresse: 8810 Tenth Ave North

Ville: Minneapolis

État: MN

Pays: USA

Code postal /Zip: 55427-4319

3.Choisir le (les) sous-formulaire(s) correspondant à l'incident.

Incident chez un animal domestique

4. Date à laquelle le titulaire d'homologation a été informé pour la première fois de l'incident.

22-OCT-14

5. Lieu de l'incident.

Pays: UNITED STATES

État: KENTUCKY

6. Date de la première observation de l'incident.

Inconnu

Description du produit

7. a) Donner le nom de la matière active et, si disponibles, le numéro d'homologation et le nom du produit (incluant tous les mélanges). Si le produit n'est pas homologué, donner le numéro de la demande d'homologation.

Matière(s) active(s)

ARLA No d'homologation       ARLA No de la demande d'homologation       EPA No d'homologation. 1021-1704-40849

Nom du produit: Flea & Tick Spray for Dogs and Cats II

  • Matière active
    • N-OCTYL BICYCLOHEPTENE DICARBOXIMIDE
      • Garantie/concentration .957 %
    • PYRETHRINS
      • Garantie/concentration .18 %
    • PYRIPROXYFEN
      • Garantie/concentration .125 %

7. b) Type de formulation.

Renseignments sur l'application

8. Est-ce que le produit a été appliqué?

Oui

9. Dose d'application.

Inconnu

10. Site d'application (choisir tout ce qui s'applique).

Site: Animal / Usage sur un animal domestique

11. Donner tout renseignement additionnel concernant l'application (comment le produit a été appliqué, la quantité utilisée, la superficie de la zone traitée, etc.)

Please refer to field 13 on Subform II or field 17 of subform III for a detailed description regarding application.

À être déterminé par le titulaire

12. Selon vous, le produit a-t-il été utilisé en conformité avec le mode d'emploi de L'étiquette?

Oui

Sous-formulaire III : Animal domestique

1. Source de la déclaration

Propriétaire de l'animal

2.Type d'animal touché

Cat / Chat

3. Race

DSH

4. Nombre d'animaux touchés

1

5. Sexe:

Homme

6. Âge (fournir un ordre de grandeur si nécessaire)

9

7. Poids (fournir un ordre de grandeur si nécessaire)

Inconnu

8. Voie(s) d'exposition:

Cutanée

9. Durée de l'exposition?

Unknown / Inconnu

10. Temps écoulé entre l'exposition et l'apparition des symptômes

>8 hrs <=24 hrs / > 8 h < = 24 h

11. Énumérer tous les symptômes

Système

  • Système gastro-intestinal
    • Symptôme - Salivation excessive
    • Symptôme - Vomit
  • General
    • Symptôme - Mort
  • Systèmes nerveux et musculaire
    • Symptôme - Ataxie
  • Système respiratoire
    • Symptôme - Respiration faible

12. Quelle a été la durée des symptômes?

Persisted until death

13. Des soins médicaux ont-ils été prodigués? Donner les détails à la question 17.

Non

14. a) Est-ce que l'animal a-t-il été hospitalisé?

Non

14. b) Combien de temps l'animal était-il hospitalisé?

Inconnu

15. Issue de l'incident

Mort

16. De quelle manière l'animal a-t-il été exposé?

Treatment / Traitement

17. Donnez tout détail additionnel au sujet de l'incident

(p.ex. description des symptômes tels que la fréquence et la gravité

11/19/2014 A report was forwarded for documentation. The report states that a consumer applied the product to her cats and dogs. The cats became ill, but the dogs remained asymptomatic. The cats developed respiratory problems, salivating, loss of balance, and vomiting. Consumer called back a week later, and reports that two of the cats died and one has still not recovered. She did not take the cats to a veterinarian, but did call the veterinarian. 11/21/2014 Call from the consumer. Caller used the product on 7 cats and 2 dogs several months ago. Cat #1 showed signs of ataxia, shortness of breath, drooling, and vomiting the next day after application. He did start to show signs of improvement but then passed away about 1 week after use. Caller noted that she bathed the cat but did not take him into a vet clinic. Cat #2 showed signs a few hours after application that progressively got worse until she passed away 2 days after application. The cat was showing signs of ataxia, shortness of breath, vomiting, and drooling. Cat #3 showed signs of ataxia, shortness of breath, vomiting, and drooling that started a few hours after use of the product. Caller syringe feed this cat, gave her subcutaneous fluids, and antibiotic injections, but did not seek veterinary care. She showed some improvement but then passed away a few months after the use of the product. Cat #4 showed signs of ataxia, drooling, diarrhea, and vomiting a few hours after application. He was bathed, given some antibiotics, and given Kaopectate for the diarrhea that had developed. He is still not using the litter box but seems to have recovered. Cat #5 showed signs of ataxia and drooling a few hours after use of the product. He still has some ataxia, but caller noted that he broke one of his limbs as a kitten and had a cast on for a period of time. No new or worsening symptoms have presented. Cat #6 showed signs of hair loss, drooling, ataxia, and had some seizure like activity after use. The symptoms now seem to have resolved. Cat #7 showed sings of salivation, vomiting, ataxia, and became anorexic a few hours after use. The symptoms now seem to have resolved. The 2 dogs did not show any signs after the use of the product.


À être déterminé par le titulaire

Classification selon la gravité (s'il y a plus d'une catégorie possible, veuillez choisir la plus grave)

Mort

19. Donner des renseignements additionnels ici

The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews. This insecticide appears to be implicated in this case simply based on a temporal but coincidental product use scenario. Incident reportedly took place several months ago. Based on the known toxicological profile of the active ingredients used in this pesticide, when this product is used in the manner described in this incident, such significant adverse effects as reported are not expected. Furthermore, these animals were never properly evaluated and treated by a DVM, nor had a necropsy been performed to determine a cause of death. The cat's prior history regarding preventative medicine such as vaccinations, deworming and feline leukemia virus was not disclosed. All cats were described as having flea infestations which also must be considered as contributing factors in their clinical outcomes.

Sous-formulaire III : Animal domestique

1. Source de la déclaration

Propriétaire de l'animal

2.Type d'animal touché

Cat / Chat

3. Race

DSH

4. Nombre d'animaux touchés

1

5. Sexe:

Femme

6. Âge (fournir un ordre de grandeur si nécessaire)

3

7. Poids (fournir un ordre de grandeur si nécessaire)

Inconnu

8. Voie(s) d'exposition:

Cutanée

9. Durée de l'exposition?

Unknown / Inconnu

10. Temps écoulé entre l'exposition et l'apparition des symptômes

>2 hrs <=8 hrs / > 2 h < = 8 h

11. Énumérer tous les symptômes

Système

  • Système gastro-intestinal
    • Symptôme - Salivation excessive
    • Symptôme - Vomit
  • General
    • Symptôme - Mort
  • Systèmes nerveux et musculaire
    • Symptôme - Ataxie
  • Système respiratoire
    • Symptôme - Respiration faible

12. Quelle a été la durée des symptômes?

Persisted until death

13. Des soins médicaux ont-ils été prodigués? Donner les détails à la question 17.

Non

14. a) Est-ce que l'animal a-t-il été hospitalisé?

Non

14. b) Combien de temps l'animal était-il hospitalisé?

Inconnu

15. Issue de l'incident

Mort

16. De quelle manière l'animal a-t-il été exposé?

Treatment / Traitement

17. Donnez tout détail additionnel au sujet de l'incident

(p.ex. description des symptômes tels que la fréquence et la gravité

11/19/2014 A report was forwarded for documentation. The report states that a consumer applied the product to her cats and dogs. The cats became ill, but the dogs remained asymptomatic. The cats developed respiratory problems, salivating, loss of balance, and vomiting. Consumer called back a week later, and reports that two of the cats died and one has still not recovered. She did not take the cats to a veterinarian, but did call the veterinarian. 11/21/2014 Call from the consumer. Caller used the product on 7 cats and 2 dogs several months ago. Cat #1 showed signs of ataxia, shortness of breath, drooling, and vomiting the next day after application. He did start to show signs of improvement but then passed away about 1 week after use. Caller noted that she bathed the cat but did not take him into a vet clinic. Cat #2 showed signs a few hours after application that progressively got worse until she passed away 2 days after application. The cat was showing signs of ataxia, shortness of breath, vomiting, and drooling. Cat #3 showed signs of ataxia, shortness of breath, vomiting, and drooling that started a few hours after use of the product. Caller syringe feed this cat, gave her subcutaneous fluids, and antibiotic injections, but did not seek veterinary care. She showed some improvement but then passed away a few months after the use of the product. Cat #4 showed signs of ataxia, drooling, diarrhea, and vomiting a few hours after application. He was bathed, given some antibiotics, and given Kaopectate for the diarrhea that had developed. He is still not using the litter box but seems to have recovered. Cat #5 showed signs of ataxia and drooling a few hours after use of the product. He still has some ataxia, but caller noted that he broke one of his limbs as a kitten and had a cast on for a period of time. No new or worsening symptoms have presented. Cat #6 showed signs of hair loss, drooling, ataxia, and had some seizure like activity after use. The symptoms now seem to have resolved. Cat #7 showed sings of salivation, vomiting, ataxia, and became anorexic a few hours after use. The symptoms now seem to have resolved. The 2 dogs did not show any signs after the use of the product.


À être déterminé par le titulaire

Classification selon la gravité (s'il y a plus d'une catégorie possible, veuillez choisir la plus grave)

Mort

19. Donner des renseignements additionnels ici

The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews. This insecticide appears to be implicated in this case simply based on a temporal but coincidental product use scenario. Incident reportedly took place several months ago. Based on the known toxicological profile of the active ingredients used in this pesticide, when this product is used in the manner described in this incident, such significant adverse effects as reported are not expected. Furthermore, these animals were never properly evaluated and treated by a DVM, nor had a necropsy been performed to determine a cause of death. The cat's prior history regarding preventative medicine such as vaccinations, deworming and feline leukemia virus was not disclosed. All cats were described as having flea infestations which also must be considered as contributing factors in their clinical outcomes.

Sous-formulaire III : Animal domestique

1. Source de la déclaration

Propriétaire de l'animal

2.Type d'animal touché

Cat / Chat

3. Race

DLH

4. Nombre d'animaux touchés

1

5. Sexe:

Femme

6. Âge (fournir un ordre de grandeur si nécessaire)

4

7. Poids (fournir un ordre de grandeur si nécessaire)

Inconnu

8. Voie(s) d'exposition:

Cutanée

9. Durée de l'exposition?

Unknown / Inconnu

10. Temps écoulé entre l'exposition et l'apparition des symptômes

>2 hrs <=8 hrs / > 2 h < = 8 h

11. Énumérer tous les symptômes

Système

  • Système gastro-intestinal
    • Symptôme - Salivation excessive
    • Symptôme - Vomit
  • General
    • Symptôme - Mort
  • Systèmes nerveux et musculaire
    • Symptôme - Ataxie
  • Système respiratoire
    • Symptôme - Respiration faible

12. Quelle a été la durée des symptômes?

Persisted until death

13. Des soins médicaux ont-ils été prodigués? Donner les détails à la question 17.

Non

14. a) Est-ce que l'animal a-t-il été hospitalisé?

Non

14. b) Combien de temps l'animal était-il hospitalisé?

Inconnu

15. Issue de l'incident

Mort

16. De quelle manière l'animal a-t-il été exposé?

Treatment / Traitement

17. Donnez tout détail additionnel au sujet de l'incident

(p.ex. description des symptômes tels que la fréquence et la gravité

11/19/2014 A report was forwarded for documentation. The report states that a consumer applied the product to her cats and dogs. The cats became ill, but the dogs remained asymptomatic. The cats developed respiratory problems, salivating, loss of balance, and vomiting. Consumer called back a week later, and reports that two of the cats died and one has still not recovered. She did not take the cats to a veterinarian, but did call the veterinarian. 11/21/2014 Call from the consumer. Caller used the product on 7 cats and 2 dogs several months ago. Cat #1 showed signs of ataxia, shortness of breath, drooling, and vomiting the next day after application. He did start to show signs of improvement but then passed away about 1 week after use. Caller noted that she bathed the cat but did not take him into a vet clinic. Cat #2 showed signs a few hours after application that progressively got worse until she passed away 2 days after application. The cat was showing signs of ataxia, shortness of breath, vomiting, and drooling. Cat #3 showed signs of ataxia, shortness of breath, vomiting, and drooling that started a few hours after use of the product. Caller syringe feed this cat, gave her subcutaneous fluids, and antibiotic injections, but did not seek veterinary care. She showed some improvement but then passed away a few months after the use of the product. Cat #4 showed signs of ataxia, drooling, diarrhea, and vomiting a few hours after application. He was bathed, given some antibiotics, and given Kaopectate for the diarrhea that had developed. He is still not using the litter box but seems to have recovered. Cat #5 showed signs of ataxia and drooling a few hours after use of the product. He still has some ataxia, but caller noted that he broke one of his limbs as a kitten and had a cast on for a period of time. No new or worsening symptoms have presented. Cat #6 showed signs of hair loss, drooling, ataxia, and had some seizure like activity after use. The symptoms now seem to have resolved. Cat #7 showed sings of salivation, vomiting, ataxia, and became anorexic a few hours after use. The symptoms now seem to have resolved. The 2 dogs did not show any signs after the use of the product.


À être déterminé par le titulaire

Classification selon la gravité (s'il y a plus d'une catégorie possible, veuillez choisir la plus grave)

Mort

19. Donner des renseignements additionnels ici

The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews. This insecticide appears to be implicated in this case simply based on a temporal but coincidental product use scenario. Incident reportedly took place several months ago. Based on the known toxicological profile of the active ingredients used in this pesticide, when this product is used in the manner described in this incident, such significant adverse effects as reported are not expected. Furthermore, these animals were never properly evaluated and treated by a DVM, nor had a necropsy been performed to determine a cause of death. The cat's prior history regarding preventative medicine such as vaccinations, deworming and feline leukemia virus was not disclosed. All cats were described as having flea infestations which also must be considered as contributing factors in their clinical outcomes.

Sous-formulaire III : Animal domestique

1. Source de la déclaration

Propriétaire de l'animal

2.Type d'animal touché

Cat / Chat

3. Race

Siamese

4. Nombre d'animaux touchés

1

5. Sexe:

Homme

6. Âge (fournir un ordre de grandeur si nécessaire)

6

7. Poids (fournir un ordre de grandeur si nécessaire)

Inconnu

8. Voie(s) d'exposition:

Cutanée

9. Durée de l'exposition?

Unknown / Inconnu

10. Temps écoulé entre l'exposition et l'apparition des symptômes

>2 hrs <=8 hrs / > 2 h < = 8 h

11. Énumérer tous les symptômes

Système

  • Système gastro-intestinal
    • Symptôme - Diarrhée
    • Symptôme - Salivation excessive
    • Symptôme - Vomit
  • Systèmes nerveux et musculaire
    • Symptôme - Ataxie

12. Quelle a été la durée des symptômes?

Unknown / Inconnu

13. Des soins médicaux ont-ils été prodigués? Donner les détails à la question 17.

Non

14. a) Est-ce que l'animal a-t-il été hospitalisé?

Non

14. b) Combien de temps l'animal était-il hospitalisé?

Inconnu

15. Issue de l'incident

Fully Recovered / Complètement rétabli

16. De quelle manière l'animal a-t-il été exposé?

Treatment / Traitement

17. Donnez tout détail additionnel au sujet de l'incident

(p.ex. description des symptômes tels que la fréquence et la gravité

11/19/2014 A report was forwarded for documentation. The report states that a consumer applied the product to her cats and dogs. The cats became ill, but the dogs remained asymptomatic. The cats developed respiratory problems, salivating, loss of balance, and vomiting. Consumer called back a week later, and reports that two of the cats died and one has still not recovered. She did not take the cats to a veterinarian, but did call the veterinarian. 11/21/2014 Call from the consumer. Caller used the product on 7 cats and 2 dogs several months ago. Cat #1 showed signs of ataxia, shortness of breath, drooling, and vomiting the next day after application. He did start to show signs of improvement but then passed away about 1 week after use. Caller noted that she bathed the cat but did not take him into a vet clinic. Cat #2 showed signs a few hours after application that progressively got worse until she passed away 2 days after application. The cat was showing signs of ataxia, shortness of breath, vomiting, and drooling. Cat #3 showed signs of ataxia, shortness of breath, vomiting, and drooling that started a few hours after use of the product. Caller syringe feed this cat, gave her subcutaneous fluids, and antibiotic injections, but did not seek veterinary care. She showed some improvement but then passed away a few months after the use of the product. Cat #4 showed signs of ataxia, drooling, diarrhea, and vomiting a few hours after application. He was bathed, given some antibiotics, and given Kaopectate for the diarrhea that had developed. He is still not using the litter box but seems to have recovered. Cat #5 showed signs of ataxia and drooling a few hours after use of the product. He still has some ataxia, but caller noted that he broke one of his limbs as a kitten and had a cast on for a period of time. No new or worsening symptoms have presented. Cat #6 showed signs of hair loss, drooling, ataxia, and had some seizure like activity after use. The symptoms now seem to have resolved. Cat #7 showed sings of salivation, vomiting, ataxia, and became anorexic a few hours after use. The symptoms now seem to have resolved. The 2 dogs did not show any signs after the use of the product.


À être déterminé par le titulaire

Classification selon la gravité (s'il y a plus d'une catégorie possible, veuillez choisir la plus grave)

Modérée

19. Donner des renseignements additionnels ici

The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews. This insecticide appears to be implicated in this case simply based on a temporal but coincidental product use scenario. Incident reportedly took place several months ago. Based on the known toxicological profile of the active ingredients used in this pesticide, when this product is used in the manner described in this incident, such significant adverse effects as reported are not expected. Furthermore, these animals were never properly evaluated and treated by a DVM, nor had a necropsy been performed to determine a cause of death. The cat's prior history regarding preventative medicine such as vaccinations, deworming and feline leukemia virus was not disclosed. All cats were described as having flea infestations which also must be considered as contributing factors in their clinical outcomes.

Sous-formulaire III : Animal domestique

1. Source de la déclaration

Propriétaire de l'animal

2.Type d'animal touché

Cat / Chat

3. Race

Siamese

4. Nombre d'animaux touchés

1

5. Sexe:

Homme

6. Âge (fournir un ordre de grandeur si nécessaire)

6

7. Poids (fournir un ordre de grandeur si nécessaire)

Inconnu

8. Voie(s) d'exposition:

Cutanée

9. Durée de l'exposition?

Unknown / Inconnu

10. Temps écoulé entre l'exposition et l'apparition des symptômes

>2 hrs <=8 hrs / > 2 h < = 8 h

11. Énumérer tous les symptômes

Système

  • Système gastro-intestinal
    • Symptôme - Salivation excessive
  • Systèmes nerveux et musculaire
    • Symptôme - Ataxie

12. Quelle a été la durée des symptômes?

Unknown / Inconnu

13. Des soins médicaux ont-ils été prodigués? Donner les détails à la question 17.

Non

14. a) Est-ce que l'animal a-t-il été hospitalisé?

Non

14. b) Combien de temps l'animal était-il hospitalisé?

Inconnu

15. Issue de l'incident

Not recovered / Non rétabli

16. De quelle manière l'animal a-t-il été exposé?

Treatment / Traitement

17. Donnez tout détail additionnel au sujet de l'incident

(p.ex. description des symptômes tels que la fréquence et la gravité

11/19/2014 A report was forwarded for documentation. The report states that a consumer applied the product to her cats and dogs. The cats became ill, but the dogs remained asymptomatic. The cats developed respiratory problems, salivating, loss of balance, and vomiting. Consumer called back a week later, and reports that two of the cats died and one has still not recovered. She did not take the cats to a veterinarian, but did call the veterinarian. 11/21/2014 Call from the consumer. Caller used the product on 7 cats and 2 dogs several months ago. Cat #1 showed signs of ataxia, shortness of breath, drooling, and vomiting the next day after application. He did start to show signs of improvement but then passed away about 1 week after use. Caller noted that she bathed the cat but did not take him into a vet clinic. Cat #2 showed signs a few hours after application that progressively got worse until she passed away 2 days after application. The cat was showing signs of ataxia, shortness of breath, vomiting, and drooling. Cat #3 showed signs of ataxia, shortness of breath, vomiting, and drooling that started a few hours after use of the product. Caller syringe feed this cat, gave her subcutaneous fluids, and antibiotic injections, but did not seek veterinary care. She showed some improvement but then passed away a few months after the use of the product. Cat #4 showed signs of ataxia, drooling, diarrhea, and vomiting a few hours after application. He was bathed, given some antibiotics, and given Kaopectate for the diarrhea that had developed. He is still not using the litter box but seems to have recovered. Cat #5 showed signs of ataxia and drooling a few hours after use of the product. He still has some ataxia, but caller noted that he broke one of his limbs as a kitten and had a cast on for a period of time. No new or worsening symptoms have presented. Cat #6 showed signs of hair loss, drooling, ataxia, and had some seizure like activity after use. The symptoms now seem to have resolved. Cat #7 showed sings of salivation, vomiting, ataxia, and became anorexic a few hours after use. The symptoms now seem to have resolved. The 2 dogs did not show any signs after the use of the product.


À être déterminé par le titulaire

Classification selon la gravité (s'il y a plus d'une catégorie possible, veuillez choisir la plus grave)

Modérée

19. Donner des renseignements additionnels ici

The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews. This insecticide appears to be implicated in this case simply based on a temporal but coincidental product use scenario. Incident reportedly took place several months ago. Based on the known toxicological profile of the active ingredients used in this pesticide, when this product is used in the manner described in this incident, such significant adverse effects as reported are not expected. Furthermore, these animals were never properly evaluated and treated by a DVM, nor had a necropsy been performed to determine a cause of death. The cat's prior history regarding preventative medicine such as vaccinations, deworming and feline leukemia virus was not disclosed. All cats were described as having flea infestations which also must be considered as contributing factors in their clinical outcomes.

Sous-formulaire III : Animal domestique

1. Source de la déclaration

Propriétaire de l'animal

2.Type d'animal touché

Cat / Chat

3. Race

DSH

4. Nombre d'animaux touchés

1

5. Sexe:

Femme

6. Âge (fournir un ordre de grandeur si nécessaire)

5

7. Poids (fournir un ordre de grandeur si nécessaire)

Inconnu

8. Voie(s) d'exposition:

Cutanée

9. Durée de l'exposition?

Unknown / Inconnu

10. Temps écoulé entre l'exposition et l'apparition des symptômes

>2 hrs <=8 hrs / > 2 h < = 8 h

11. Énumérer tous les symptômes

Système

  • Système gastro-intestinal
    • Symptôme - Salivation excessive
    • Symptôme - Vomit
  • Systèmes nerveux et musculaire
    • Symptôme - Ataxie
    • Symptôme - Crise
  • Peau
    • Symptôme - Perte de cheveux

12. Quelle a été la durée des symptômes?

Unknown / Inconnu

13. Des soins médicaux ont-ils été prodigués? Donner les détails à la question 17.

Non

14. a) Est-ce que l'animal a-t-il été hospitalisé?

Non

14. b) Combien de temps l'animal était-il hospitalisé?

Inconnu

15. Issue de l'incident

Fully Recovered / Complètement rétabli

16. De quelle manière l'animal a-t-il été exposé?

Treatment / Traitement

17. Donnez tout détail additionnel au sujet de l'incident

(p.ex. description des symptômes tels que la fréquence et la gravité

11/19/2014 A report was forwarded for documentation. The report states that a consumer applied the product to her cats and dogs. The cats became ill, but the dogs remained asymptomatic. The cats developed respiratory problems, salivating, loss of balance, and vomiting. Consumer called back a week later, and reports that two of the cats died and one has still not recovered. She did not take the cats to a veterinarian, but did call the veterinarian. 11/21/2014 Call from the consumer. Caller used the product on 7 cats and 2 dogs several months ago. Cat #1 showed signs of ataxia, shortness of breath, drooling, and vomiting the next day after application. He did start to show signs of improvement but then passed away about 1 week after use. Caller noted that she bathed the cat but did not take him into a vet clinic. Cat #2 showed signs a few hours after application that progressively got worse until she passed away 2 days after application. The cat was showing signs of ataxia, shortness of breath, vomiting, and drooling. Cat #3 showed signs of ataxia, shortness of breath, vomiting, and drooling that started a few hours after use of the product. Caller syringe feed this cat, gave her subcutaneous fluids, and antibiotic injections, but did not seek veterinary care. She showed some improvement but then passed away a few months after the use of the product. Cat #4 showed signs of ataxia, drooling, diarrhea, and vomiting a few hours after application. He was bathed, given some antibiotics, and given Kaopectate for the diarrhea that had developed. He is still not using the litter box but seems to have recovered. Cat #5 showed signs of ataxia and drooling a few hours after use of the product. He still has some ataxia, but caller noted that he broke one of his limbs as a kitten and had a cast on for a period of time. No new or worsening symptoms have presented. Cat #6 showed signs of hair loss, drooling, ataxia, and had some seizure like activity after use. The symptoms now seem to have resolved. Cat #7 showed sings of salivation, vomiting, ataxia, and became anorexic a few hours after use. The symptoms now seem to have resolved. The 2 dogs did not show any signs after the use of the product.


À être déterminé par le titulaire

Classification selon la gravité (s'il y a plus d'une catégorie possible, veuillez choisir la plus grave)

Modérée

19. Donner des renseignements additionnels ici

The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews. This insecticide appears to be implicated in this case simply based on a temporal but coincidental product use scenario. Incident reportedly took place several months ago. Based on the known toxicological profile of the active ingredients used in this pesticide, when this product is used in the manner described in this incident, such significant adverse effects as reported are not expected. Furthermore, these animals were never properly evaluated and treated by a DVM, nor had a necropsy been performed to determine a cause of death. The cat's prior history regarding preventative medicine such as vaccinations, deworming and feline leukemia virus was not disclosed. All cats were described as having flea infestations which also must be considered as contributing factors in their clinical outcomes.

Sous-formulaire III : Animal domestique

1. Source de la déclaration

Propriétaire de l'animal

2.Type d'animal touché

Cat / Chat

3. Race

DSH

4. Nombre d'animaux touchés

1

5. Sexe:

Homme

6. Âge (fournir un ordre de grandeur si nécessaire)

9

7. Poids (fournir un ordre de grandeur si nécessaire)

Inconnu

8. Voie(s) d'exposition:

Cutanée

9. Durée de l'exposition?

Unknown / Inconnu

10. Temps écoulé entre l'exposition et l'apparition des symptômes

>2 hrs <=8 hrs / > 2 h < = 8 h

11. Énumérer tous les symptômes

Système

  • Système gastro-intestinal
    • Symptôme - Anorexie
    • Symptôme - Salivation excessive
    • Symptôme - Vomit
  • Systèmes nerveux et musculaire
    • Symptôme - Ataxie

12. Quelle a été la durée des symptômes?

Unknown / Inconnu

13. Des soins médicaux ont-ils été prodigués? Donner les détails à la question 17.

Non

14. a) Est-ce que l'animal a-t-il été hospitalisé?

Non

14. b) Combien de temps l'animal était-il hospitalisé?

Inconnu

15. Issue de l'incident

Fully Recovered / Complètement rétabli

16. De quelle manière l'animal a-t-il été exposé?

Treatment / Traitement

17. Donnez tout détail additionnel au sujet de l'incident

(p.ex. description des symptômes tels que la fréquence et la gravité

11/19/2014 A report was forwarded for documentation. The report states that a consumer applied the product to her cats and dogs. The cats became ill, but the dogs remained asymptomatic. The cats developed respiratory problems, salivating, loss of balance, and vomiting. Consumer called back a week later, and reports that two of the cats died and one has still not recovered. She did not take the cats to a veterinarian, but did call the veterinarian. 11/21/2014 Call from the consumer. Caller used the product on 7 cats and 2 dogs several months ago. Cat #1 showed signs of ataxia, shortness of breath, drooling, and vomiting the next day after application. He did start to show signs of improvement but then passed away about 1 week after use. Caller noted that she bathed the cat but did not take him into a vet clinic. Cat #2 showed signs a few hours after application that progressively got worse until she passed away 2 days after application. The cat was showing signs of ataxia, shortness of breath, vomiting, and drooling. Cat #3 showed signs of ataxia, shortness of breath, vomiting, and drooling that started a few hours after use of the product. Caller syringe feed this cat, gave her subcutaneous fluids, and antibiotic injections, but did not seek veterinary care. She showed some improvement but then passed away a few months after the use of the product. Cat #4 showed signs of ataxia, drooling, diarrhea, and vomiting a few hours after application. He was bathed, given some antibiotics, and given Kaopectate for the diarrhea that had developed. He is still not using the litter box but seems to have recovered. Cat #5 showed signs of ataxia and drooling a few hours after use of the product. He still has some ataxia, but caller noted that he broke one of his limbs as a kitten and had a cast on for a period of time. No new or worsening symptoms have presented. Cat #6 showed signs of hair loss, drooling, ataxia, and had some seizure like activity after use. The symptoms now seem to have resolved. Cat #7 showed sings of salivation, vomiting, ataxia, and became anorexic a few hours after use. The symptoms now seem to have resolved. The 2 dogs did not show any signs after the use of the product.


À être déterminé par le titulaire

Classification selon la gravité (s'il y a plus d'une catégorie possible, veuillez choisir la plus grave)

Modérée

19. Donner des renseignements additionnels ici

The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews. This insecticide appears to be implicated in this case simply based on a temporal but coincidental product use scenario. Incident reportedly took place several months ago. Based on the known toxicological profile of the active ingredients used in this pesticide, when this product is used in the manner described in this incident, such significant adverse effects as reported are not expected. Furthermore, these animals were never properly evaluated and treated by a DVM, nor had a necropsy been performed to determine a cause of death. The cat's prior history regarding preventative medicine such as vaccinations, deworming and feline leukemia virus was not disclosed. All cats were described as having flea infestations which also must be considered as contributing factors in their clinical outcomes.